These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 19124510
1. Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma. Birmann BM, Tamimi RM, Giovannucci E, Rosner B, Hunter DJ, Kraft P, Mitsiades C, Anderson KC, Colditz GA. Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):282-8. PubMed ID: 19124510 [Abstract] [Full Text] [Related]
2. Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival. Nielsen KR, Rodrigo-Domingo M, Steffensen R, Baech J, Bergkvist KS, Oosterhof L, Schmitz A, Bødker JS, Johansen P, Vogel U, Vangsted A, Dybkær K, Bøgsted M, Johnsen HE. Leuk Lymphoma; 2017 Nov; 58(11):2695-2704. PubMed ID: 28393658 [Abstract] [Full Text] [Related]
4. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Terry KL, Tworoger SS, Gates MA, Cramer DW, Hankinson SE. Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071 [Abstract] [Full Text] [Related]
5. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B, Neuhausen S. Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132 [Abstract] [Full Text] [Related]
6. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis. Shi Q, Wang XS, Li G, Shah ND, Orlowski RZ, Williams LA, Mendoza TR, Cleeland CS. Cancer; 2015 Apr 01; 121(7):1138-46. PubMed ID: 25469832 [Abstract] [Full Text] [Related]
10. Common genetic variation in the IGF1 associates with maximal force output. Huuskonen A, Lappalainen J, Oksala N, Santtila M, Häkkinen K, Kyröläinen H, Atalay M. Med Sci Sports Exerc; 2011 Dec 01; 43(12):2368-74. PubMed ID: 21552154 [Abstract] [Full Text] [Related]
11. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study. Deming SL, Ren Z, Wen W, Shu XO, Cai Q, Gao YT, Zheng W. Breast Cancer Res Treat; 2007 Sep 01; 104(3):309-19. PubMed ID: 17063263 [Abstract] [Full Text] [Related]
12. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density. Taverne CW, Verheus M, McKay JD, Kaaks R, Canzian F, Grobbee DE, Peeters PH, van Gils CH. Breast Cancer Res Treat; 2010 Oct 01; 123(3):843-55. PubMed ID: 20155489 [Abstract] [Full Text] [Related]
13. Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk. Jung SY, Rohan T, Strickler H, Bea J, Zhang ZF, Ho G, Crandall C. PLoS One; 2017 Oct 01; 12(10):e0186296. PubMed ID: 29023587 [Abstract] [Full Text] [Related]
15. Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Birmann BM, Neuhouser ML, Rosner B, Albanes D, Buring JE, Giles GG, Lan Q, Lee IM, Purdue MP, Rothman N, Severi G, Yuan JM, Anderson KC, Pollak M, Rifai N, Hartge P, Landgren O, Lessin L, Virtamo J, Wallace RB, Manson JE, Colditz GA. Blood; 2012 Dec 13; 120(25):4929-37. PubMed ID: 23074271 [Abstract] [Full Text] [Related]
16. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese. Wong HL, Delellis K, Probst-Hensch N, Koh WP, Van Den Berg D, Lee HP, Yu MC, Ingles SA. Cancer Epidemiol Biomarkers Prev; 2005 Jan 13; 14(1):144-51. PubMed ID: 15668488 [Abstract] [Full Text] [Related]